the present invention relates to novel heterocyclic antagonists of formula and pharmaceutical compositions comprising said antagonists of the corticotropin releasing factor receptor useful for the treatment of depression , anxiety , affective disorders , feeding disorders , post - traumatic stress disorder , headache , drug addiction , inflammatory disorders , drug or alcohol withdrawal symptoms and other conditions the treatment of which can be effected by the antagonism of the crf - 1 receptor .